Arrastia, Mary V. http://orcid.org/0000-0002-0723-3574
Jachowicz, Joanna W. http://orcid.org/0000-0002-1599-682X
Ollikainen, Noah
Curtis, Matthew S. http://orcid.org/0000-0002-9662-3266
Lai, Charlotte
Quinodoz, Sofia A. http://orcid.org/0000-0003-1862-5204
Selck, David A. http://orcid.org/0000-0002-0591-4165
Ismagilov, Rustem F. http://orcid.org/0000-0002-3680-4399
Guttman, Mitchell http://orcid.org/0000-0003-4748-9352
Funding for this research was provided by:
National Science Foundation (DGE-144469, DGE-144469)
U.S. Department of Health & Human Services | National Institutes of Health (U01 HL130007, U01 DA040612, U01 DA040612 and U01 HL130007)
New York Stem Cell Foundation (NYSCF-R-I13, NYSCF-R-I13)
Sontag Foundation
California Institute of Technology
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (U01 HG007910)
Sontag Foundation; California Institute of Technology
Article History
Received: 20 July 2020
Accepted: 25 June 2021
First Online: 23 August 2021
Competing interests
: This paper is the subject of a patent application filed by Caltech. R.F.I. has a financial interest in Talis Biomedical Corp. S.A.Q. and M.G. are inventors on a patent owned by Caltech on SPRITE. The remaining authors declare no competing financial interests.